[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

E. Coli Testing Market 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

December 2016 | 200 pages | ID: E376D14B629EN
Venture Planning Group

US$ 3,480.00 US$ 4,350.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 200 pages and 7 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
  ROLE OF ESCHERICHIA COLI IN
  Causing Diarrhea
  EPEC
  ETEC
  EIEC
  EHEC
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. DNA PROBES
    a. Technology Overview
    b. Amplification Methods
      POLYMERASE CHAIN REACTION
      Robotics
      Temperature Cyclers
      PCR Variations
      IMMUNO-PCR
      QC-PCR
      DAP-PCR
      LIGASE CHAIN REACTION
      BRANCHED DNA
      Q-BETA REPLICASE
      NUCLEIC-ACID SEQUENCE-BASED
      STRAND DISPLACEMENT ACTIVATION
      SELF-SUSTAINED SEQUENCE REPLICASE
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      OVERVIEW
      ELISA
      DOT IMMUNOBINDING ASSAYS
      CAPILLARY IMMUNOASSAYS
      PARTICLE-MEMBRANE CAPTURE IMMUNOASSAYS
      ENZYME AMPLIFICATION
    c. Fluorescent Immunoassays
      FLUORESCENCE POLARIZATION
      TIME-RESOLVED PULSE FLUORESCENCE
    d. Luminescence
      CHEMILUMINESCENCE
      BIOLUMINESCENCE
    e. Latex Agglutination
    f. Immunoprecipitation
  4. DIFFERENTIAL LIGHT SCATTERING
  5. MICROCOMPUTERS AND AUTOMATION
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. MRI
  11. GEL MICRODROPLETS
  12. OTHER

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus

E. COLI DIAGNOSTICS MARKET: US, EUROPE, JAPAN TEST VOLUME AND SALES FORECASTS BY COUNTRY

LIST OF TABLES

France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Germany E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Italy E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Japan E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Spain E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment


More Publications